Design, modification, and bio-evaluation of salazinic acid derivatives

Data on synthesized derivatives of salazinic acid are scarce, with existing reports addressing only derivative hexaacetyl salazinic acid. This study investigated a set of novel potential antidiabetic agents. Analogs of salazinic acid were designed and synthesized using bromination, nucleophilic addi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nguyen-Kim-Tuyen Pham, Nguyen-Minh-An Tran, Huy Truong Nguyen, Duc-Dung Pham, Thi-Quynh-Trang Nguyen, Thi-Hong-Anh Nguyen, Huu-Tri Nguyen, Thanh-Hung Do, Ngoc-Hong Nguyen, Thuc-Huy Duong
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/fb74b27e54f54a419bbf36b29bbda4e8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fb74b27e54f54a419bbf36b29bbda4e8
record_format dspace
spelling oai:doaj.org-article:fb74b27e54f54a419bbf36b29bbda4e82021-11-26T04:26:07ZDesign, modification, and bio-evaluation of salazinic acid derivatives1878-535210.1016/j.arabjc.2021.103535https://doaj.org/article/fb74b27e54f54a419bbf36b29bbda4e82022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1878535221005505https://doaj.org/toc/1878-5352Data on synthesized derivatives of salazinic acid are scarce, with existing reports addressing only derivative hexaacetyl salazinic acid. This study investigated a set of novel potential antidiabetic agents. Analogs of salazinic acid were designed and synthesized using bromination, nucleophilic addition, Friedel-Crafts alkylation, and esterification. Ten synthetic compounds were prepared and structurally elucidated, including eight new compounds (1a-1c, 2a, 3a, 3b, 4a, 4b) and two known analogs. Under bromination, salazinic acid (1) enabled the following reaction chain: oxidation, decarboxylation, and substitution. This yielded products 1a-1c, which were found to have unprecedented scaffolds. Parmosidone F (5) was prepared from 1 with orsellinic acid via Friedel-Crafts alkylation, confirming a previously reported biosynthesis route. These analogs were evaluated for enzyme inhibition of α-glucosidase, and all showed more potent activity than that of acarbose, a positive control (IC50 332 μM), with IC50 values in the range 9.32–39.96 μM. An in silico molecular docking model confirmed that, in terms of enzyme inhibition, the compounds ranked as follows: 3b > 4b > 4a > 1c > 2a > 1b > 1a > 3a. The kinetics of enzyme inhibition showed 4a and 5 to be a non-competitive-type and mixed-type inhibitors, respectively.Nguyen-Kim-Tuyen PhamNguyen-Minh-An TranHuy Truong NguyenDuc-Dung PhamThi-Quynh-Trang NguyenThi-Hong-Anh NguyenHuu-Tri NguyenThanh-Hung DoNgoc-Hong NguyenThuc-Huy DuongElsevierarticleLichenBrominationNucleophilic additionα-glucosidase inhibitionMolecular dockingKineticChemistryQD1-999ENArabian Journal of Chemistry, Vol 15, Iss 1, Pp 103535- (2022)
institution DOAJ
collection DOAJ
language EN
topic Lichen
Bromination
Nucleophilic addition
α-glucosidase inhibition
Molecular docking
Kinetic
Chemistry
QD1-999
spellingShingle Lichen
Bromination
Nucleophilic addition
α-glucosidase inhibition
Molecular docking
Kinetic
Chemistry
QD1-999
Nguyen-Kim-Tuyen Pham
Nguyen-Minh-An Tran
Huy Truong Nguyen
Duc-Dung Pham
Thi-Quynh-Trang Nguyen
Thi-Hong-Anh Nguyen
Huu-Tri Nguyen
Thanh-Hung Do
Ngoc-Hong Nguyen
Thuc-Huy Duong
Design, modification, and bio-evaluation of salazinic acid derivatives
description Data on synthesized derivatives of salazinic acid are scarce, with existing reports addressing only derivative hexaacetyl salazinic acid. This study investigated a set of novel potential antidiabetic agents. Analogs of salazinic acid were designed and synthesized using bromination, nucleophilic addition, Friedel-Crafts alkylation, and esterification. Ten synthetic compounds were prepared and structurally elucidated, including eight new compounds (1a-1c, 2a, 3a, 3b, 4a, 4b) and two known analogs. Under bromination, salazinic acid (1) enabled the following reaction chain: oxidation, decarboxylation, and substitution. This yielded products 1a-1c, which were found to have unprecedented scaffolds. Parmosidone F (5) was prepared from 1 with orsellinic acid via Friedel-Crafts alkylation, confirming a previously reported biosynthesis route. These analogs were evaluated for enzyme inhibition of α-glucosidase, and all showed more potent activity than that of acarbose, a positive control (IC50 332 μM), with IC50 values in the range 9.32–39.96 μM. An in silico molecular docking model confirmed that, in terms of enzyme inhibition, the compounds ranked as follows: 3b > 4b > 4a > 1c > 2a > 1b > 1a > 3a. The kinetics of enzyme inhibition showed 4a and 5 to be a non-competitive-type and mixed-type inhibitors, respectively.
format article
author Nguyen-Kim-Tuyen Pham
Nguyen-Minh-An Tran
Huy Truong Nguyen
Duc-Dung Pham
Thi-Quynh-Trang Nguyen
Thi-Hong-Anh Nguyen
Huu-Tri Nguyen
Thanh-Hung Do
Ngoc-Hong Nguyen
Thuc-Huy Duong
author_facet Nguyen-Kim-Tuyen Pham
Nguyen-Minh-An Tran
Huy Truong Nguyen
Duc-Dung Pham
Thi-Quynh-Trang Nguyen
Thi-Hong-Anh Nguyen
Huu-Tri Nguyen
Thanh-Hung Do
Ngoc-Hong Nguyen
Thuc-Huy Duong
author_sort Nguyen-Kim-Tuyen Pham
title Design, modification, and bio-evaluation of salazinic acid derivatives
title_short Design, modification, and bio-evaluation of salazinic acid derivatives
title_full Design, modification, and bio-evaluation of salazinic acid derivatives
title_fullStr Design, modification, and bio-evaluation of salazinic acid derivatives
title_full_unstemmed Design, modification, and bio-evaluation of salazinic acid derivatives
title_sort design, modification, and bio-evaluation of salazinic acid derivatives
publisher Elsevier
publishDate 2022
url https://doaj.org/article/fb74b27e54f54a419bbf36b29bbda4e8
work_keys_str_mv AT nguyenkimtuyenpham designmodificationandbioevaluationofsalazinicacidderivatives
AT nguyenminhantran designmodificationandbioevaluationofsalazinicacidderivatives
AT huytruongnguyen designmodificationandbioevaluationofsalazinicacidderivatives
AT ducdungpham designmodificationandbioevaluationofsalazinicacidderivatives
AT thiquynhtrangnguyen designmodificationandbioevaluationofsalazinicacidderivatives
AT thihonganhnguyen designmodificationandbioevaluationofsalazinicacidderivatives
AT huutringuyen designmodificationandbioevaluationofsalazinicacidderivatives
AT thanhhungdo designmodificationandbioevaluationofsalazinicacidderivatives
AT ngochongnguyen designmodificationandbioevaluationofsalazinicacidderivatives
AT thuchuyduong designmodificationandbioevaluationofsalazinicacidderivatives
_version_ 1718409942590816256